Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 61

1.

Clinicopathologic features and treatment in patients with early stage uterine clear cell carcinoma: A 16-year experience.

Armbruster SD, Previs R, Soliman PT, Westin SN, Fellman B, Jhingran A, Fleming ND.

Gynecol Oncol. 2019 Jun 18. pii: S0090-8258(19)31278-8. doi: 10.1016/j.ygyno.2019.06.001. [Epub ahead of print]

PMID:
31221496
2.

Simulating Time-Dependent Patterns of Nonadherence by Patients With Breast Cancer to Adjuvant Oral Endocrine Therapy.

Shinn EH, Broderick G, Fellman B, Johnson A, Wieland E, Moulder S, Symmans WF.

JCO Clin Cancer Inform. 2019 Apr;3:1-9. doi: 10.1200/CCI.18.00091.

3.

Incidence of Bleeding Complications With Flexible Bronchoscopy in Cancer Patients With Thrombocytopenia.

Faiz SA, Jimenez CA, Fellman BM, Huk T, Jazbeh S, Haque SA, Morice RC, Grosu HB, Balachandran DD, Shannon VR, Eapen GA, Bashoura L.

J Bronchology Interv Pulmonol. 2019 Apr 9. doi: 10.1097/LBR.0000000000000590. [Epub ahead of print]

PMID:
30973520
4.

Outcomes of nonmetastatic micropapillary variant upper tract urothelial carcinoma.

Duplisea JJ, Petros FG, Li R, Fellman B, Guo CC, Czerniak BA, Siefker-Radtke AO, Araujo JC, Dinney CPN, Matin SF.

Urol Oncol. 2019 Jun;37(6):354.e19-354.e26. doi: 10.1016/j.urolonc.2019.01.026. Epub 2019 Feb 16.

PMID:
30777393
5.

Perceptions of Missed Care Across Oncology Nursing Specialty Units.

Villamin C, Anderson J, Fellman B, Urbauer D, Brassil K.

J Nurs Care Qual. 2019 Jan/Mar;34(1):47-53. doi: 10.1097/NCQ.0000000000000324.

PMID:
30475323
6.

Prognostic factors impacting survival in early stage uterine carcinosarcoma.

Kurnit KC, Previs RA, Soliman PT, Westin SN, Klopp AH, Fellman BM, Lu KH, Ramondetta LM, Fleming ND.

Gynecol Oncol. 2019 Jan;152(1):31-37. doi: 10.1016/j.ygyno.2018.10.034. Epub 2018 Nov 8.

PMID:
30414738
7.

Concordance of a laparoscopic scoring algorithm with primary surgery findings in advanced stage ovarian cancer.

Hansen JM, Sood AK, Coleman RL, Westin SN, Soliman PT, Ramirez PT, Fellman BM, Schmeler KM, Fleming ND.

Gynecol Oncol. 2018 Dec;151(3):428-432. doi: 10.1016/j.ygyno.2018.10.017. Epub 2018 Oct 23.

PMID:
30366647
8.

Identification of a subset of microsatellite-stable endometrial carcinoma with high PD-L1 and CD8+ lymphocytes.

Crumley S, Kurnit K, Hudgens C, Fellman B, Tetzlaff MT, Broaddus R.

Mod Pathol. 2019 Mar;32(3):396-404. doi: 10.1038/s41379-018-0148-x. Epub 2018 Oct 5.

9.

Survival in Differentiated Thyroid Cancer: Comparing the AJCC Cancer Staging Seventh and Eighth Editions.

Tam S, Boonsripitayanon M, Amit M, Fellman BM, Li Y, Busaidy NL, Cabanillas ME, Dadu R, Sherman S, Waguespack SG, Williams MD, Goepfert RP, Gross ND, Perrier ND, Sturgis EM, Zafereo ME.

Thyroid. 2018 Oct;28(10):1301-1310. doi: 10.1089/thy.2017.0572.

PMID:
30141373
10.

Laparoscopic Surgical Algorithm to Triage the Timing of Tumor Reductive Surgery in Advanced Ovarian Cancer.

Fleming ND, Nick AM, Coleman RL, Westin SN, Ramirez PT, Soliman PT, Fellman B, Meyer LA, Schmeler KM, Lu KH, Sood AK.

Obstet Gynecol. 2018 Sep;132(3):545-554. doi: 10.1097/AOG.0000000000002796.

PMID:
30095787
11.

Conditional survival of patients with small renal masses undergoing active surveillance.

Petros FG, Venkatesan AM, Kaya D, Ng CS, Fellman BM, Karam JA, Wood CG, Matin SF.

BJU Int. 2019 Mar;123(3):447-455. doi: 10.1111/bju.14486. Epub 2018 Aug 27.

PMID:
30007044
12.

Prospective Randomized Biomarker Study of Metformin and Lifestyle Intervention for Prevention in Obese Women at Increased Risk for Endometrial Cancer.

Yates MS, Coletta AM, Zhang Q, Schmandt RE, Medepalli M, Nebgen D, Soletsky B, Milbourne A, Levy E, Fellman B, Urbauer D, Yuan Y, Broaddus RR, Basen-Engquist K, Lu K.

Cancer Prev Res (Phila). 2018 Aug;11(8):477-490. doi: 10.1158/1940-6207.CAPR-17-0398. Epub 2018 May 1.

PMID:
29716897
13.

Multimodal Imaging of Pathologic Response to Chemoradiation in Esophageal Cancer.

Fang P, Musall BC, Son JB, Moreno AC, Hobbs BP, Carter BW, Fellman BM, Mawlawi O, Ma J, Lin SH.

Int J Radiat Oncol Biol Phys. 2018 Nov 15;102(4):996-1001. doi: 10.1016/j.ijrobp.2018.02.029. Epub 2018 Mar 2.

PMID:
29685377
14.

Variations in Missed Care Across Oncology Nursing Specialty Units.

Villamin C, Anderson J, Fellman B, Urbauer D, Brassil K.

J Nurs Care Qual. 2018 Apr 19. doi: 10.1097/NCQ.0000000000000324. [Epub ahead of print]

PMID:
29677025
15.

Intraoperative Conversion From Partial to Radical Nephrectomy: Incidence, Predictive Factors, and Outcomes.

Petros FG, Keskin SK, Yu KJ, Li R, Metcalfe MJ, Fellman BM, Chang CM, Gu C, Tamboli P, Matin SF, Karam JA, Wood CG.

Urology. 2018 Jun;116:114-119. doi: 10.1016/j.urology.2018.03.017. Epub 2018 Mar 22.

PMID:
29578041
16.

Oncologic outcomes of patients with positive surgical margin after partial nephrectomy: a 25-year single institution experience.

Petros FG, Metcalfe MJ, Yu KJ, Keskin SK, Fellman BM, Chang CM, Gu C, Tamboli P, Matin SF, Karam JA, Wood CG.

World J Urol. 2018 Jul;36(7):1093-1101. doi: 10.1007/s00345-018-2241-7. Epub 2018 Feb 27.

PMID:
29488096
17.

Adolescent-young adults (AYA) with cancer seeking integrative oncology consultations: demographics, characteristics, and self-reported outcomes.

Lopez G, Liu W, Madden K, Fellman B, Li Y, Bruera E.

Support Care Cancer. 2018 Apr;26(4):1161-1167. doi: 10.1007/s00520-017-3937-8. Epub 2017 Oct 29.

PMID:
29082436
18.

Management of the lateral neck compartment in patients with sporadic medullary thyroid cancer.

Pena I, Clayman GL, Grubbs EG, Bergeron JM Jr, Waguespack SG, Cabanillas ME, Dadu R, Hu MI, Fellman BM, Li Y, Gross ND, Lai SY, Sturgis EM, Zafereo ME.

Head Neck. 2018 Jan;40(1):79-85. doi: 10.1002/hed.24969. Epub 2017 Oct 16.

PMID:
29044788
19.

Complementary and Alternative Medicine Use in Minority and Medically Underserved Oncology Patients: Assessment and Implications.

Jones D, Cohen L, Rieber AG, Urbauer D, Fellman B, Fisch MJ, Nazario A.

Integr Cancer Ther. 2018 Jun;17(2):371-379. doi: 10.1177/1534735417735892. Epub 2017 Oct 13.

20.

The diagnostic accuracy of neck ultrasound, 4D-Computed tomographyand sestamibi imaging in parathyroid carcinoma.

Christakis I, Vu T, Chuang HH, Fellman B, Figueroa AMS, Williams MD, Busaidy NL, Perrier ND.

Eur J Radiol. 2017 Oct;95:82-88. doi: 10.1016/j.ejrad.2017.07.026. Epub 2017 Aug 1.

PMID:
28987702
21.

Programmed cell death ligand 1 and tumor-infiltrating lymphocyte status in patients with renal cell carcinoma and sarcomatoid dedifferentiation.

Kawakami F, Sircar K, Rodriguez-Canales J, Fellman BM, Urbauer DL, Tamboli P, Tannir NM, Jonasch E, Wistuba II, Wood CG, Karam JA.

Cancer. 2017 Dec 15;123(24):4823-4831. doi: 10.1002/cncr.30937. Epub 2017 Aug 22.

22.

Integrative Oncology Outpatient Consultations: Long-Term Effects on Patient-Reported Symptoms and Quality of Life.

Lopez G, Liu W, McQuade J, Lee RT, Spelman AR, Fellman B, Li Y, Bruera E, Cohen L.

J Cancer. 2017 Jun 3;8(9):1640-1646. doi: 10.7150/jca.18875. eCollection 2017.

23.

Chemomobilization: Overview of an Educational Quality Improvement Project for Recipients of Autologous Stem Cell Transplantation.

Rivera ZR, Nurse R, Fellman B, Brunelle N, Brassil KJ.

Clin J Oncol Nurs. 2017 Aug 1;21(4):E106-E113. doi: 10.1188/17.CJON.E106-E113. Review.

PMID:
28738047
24.

Longitudinal Outcomes of an Institutionally Developed Nurse Residency Program.

Cline D, La Frentz K, Fellman B, Summers B, Brassil K.

J Nurs Adm. 2017 Jul/Aug;47(7-8):384-390. doi: 10.1097/NNA.0000000000000500.

25.

The Effects of Neoadjuvant Axitinib on Anthropometric Parameters in Patients With Locally Advanced Non-metastatic Renal Cell Carcinoma.

Chéry L, Borregales LD, Fellman B, Urbauer DL, Garg N, Parker N, Katz MHG, Wood CG, Karam JA.

Urology. 2017 Oct;108:114-121. doi: 10.1016/j.urology.2017.05.056. Epub 2017 Jul 10.

26.

Quality of life among long-term survivors of advanced stage ovarian cancer: A cross-sectional approach.

Lutgendorf SK, Shinn E, Carter J, Leighton S, Baggerly K, Guindani M, Fellman B, Matzo M, Slavich GM, Goodman MT, Tew W, Lester J, Moore KM, Karlan BY, Levine DA, Sood AK.

Gynecol Oncol. 2017 Jul;146(1):101-108. doi: 10.1016/j.ygyno.2017.05.008. Epub 2017 May 17.

27.

CTNNB1 (beta-catenin) mutation identifies low grade, early stage endometrial cancer patients at increased risk of recurrence.

Kurnit KC, Kim GN, Fellman BM, Urbauer DL, Mills GB, Zhang W, Broaddus RR.

Mod Pathol. 2017 Jul;30(7):1032-1041. doi: 10.1038/modpathol.2017.15. Epub 2017 Mar 10.

28.

Integrative Oncology Physician Consultations at a Comprehensive Cancer Center: Analysis of Demographic, Clinical and Patient Reported Outcomes.

Lopez G, McQuade J, Cohen L, Williams JT, Spelman AR, Fellman B, Li Y, Bruera E, Lee RT.

J Cancer. 2017 Feb 10;8(3):395-402. doi: 10.7150/jca.17506. eCollection 2017.

29.

Characterization of oral and gut microbiome temporal variability in hospitalized cancer patients.

Galloway-Peña JR, Smith DP, Sahasrabhojane P, Wadsworth WD, Fellman BM, Ajami NJ, Shpall EJ, Daver N, Guindani M, Petrosino JF, Kontoyiannis DP, Shelburne SA.

Genome Med. 2017 Feb 28;9(1):21. doi: 10.1186/s13073-017-0409-1.

30.

Clinical Challenges Associated with Universal Screening for Lynch Syndrome-Associated Endometrial Cancer.

Bruegl AS, Ring KL, Daniels M, Fellman BM, Urbauer DL, Broaddus RR.

Cancer Prev Res (Phila). 2017 Feb;10(2):108-115. doi: 10.1158/1940-6207.CAPR-16-0219. Epub 2016 Dec 13.

31.

Cancer screening behaviors and risk perceptions among family members of colorectal cancer patients with unexplained mismatch repair deficiency.

Katz LH, Advani S, Burton-Chase AM, Fellman B, Polivka KM, Yuan Y, Lynch PM, Peterson SK.

Fam Cancer. 2017 Apr;16(2):231-237. doi: 10.1007/s10689-016-9947-8.

32.

Effect of routine screening for sexual problems in a breast cancer survivorship clinic.

Bradford A, Fellman B, Urbauer D, Bevers T.

Psychooncology. 2016 Nov;25(11):1375-1378. doi: 10.1002/pon.3999. Epub 2015 Oct 9. No abstract available.

33.

Endometrial Cancer Associated Symptoms: A Case-Control Study.

Pakish JB, Lu KH, Sun CC, Burzawa JK, Greisinger A, Smith FA, Fellman B, Urbauer DL, Soliman PT.

J Womens Health (Larchmt). 2016 Nov;25(11):1187-1192. Epub 2016 Jun 2.

34.

Withdrawal of Heart Failure Medications in Cancer Survivors With Chemotherapy-Induced Left Ventricular Dysfunction: A Pilot Study.

Fadol AP, Banchs J, Hassan SA, Yeh ET, Fellman B.

J Card Fail. 2016 Jun;22(6):481-2. doi: 10.1016/j.cardfail.2016.03.011. Epub 2016 Mar 29. No abstract available.

PMID:
27036866
35.

Patient knowledge and information-seeking about personalized cancer therapy.

Rogith D, Yusuf RA, Hovick SR, Fellman BM, Peterson SK, Burton-Chase AM, Li Y, Bernstam EV, Meric-Bernstam F.

Int J Med Inform. 2016 Apr;88:52-7. doi: 10.1016/j.ijmedinf.2016.01.005. Epub 2016 Jan 18.

36.

Depression and Oropharynx Cancer Outcome.

Shinn EH, Valentine A, Jethanandani A, Basen-Engquist K, Fellman B, Urbauer D, Atkinson E, Yusuf SW, Lenihan D, Woods ML, Kies MS, Sood AK, Carmack C, Morrison WH, Gillenwater A, Sturgis EM, Garden AS.

Psychosom Med. 2016 Jan;78(1):38-48. doi: 10.1097/PSY.0000000000000256.

37.

Assessment of sexual activity and dysfunction in medically underserved women with gynecologic cancers.

Bradford A, Fellman B, Urbauer D, Gallegos J, Meaders K, Tung C, Ramondetta L.

Gynecol Oncol. 2015 Oct;139(1):134-40. doi: 10.1016/j.ygyno.2015.08.019. Epub 2015 Aug 29.

38.

Screening adherence and cancer risk perceptions in colorectal cancer survivors with Lynch-like syndrome.

Katz LH, Burton-Chase AM, Advani S, Fellman B, Polivka KM, Yuan Y, Lynch PM, Peterson SK.

Clin Genet. 2016 Mar;89(3):392-8. doi: 10.1111/cge.12653. Epub 2015 Sep 14.

39.

Metastases to the kidney: a comprehensive analysis of 151 patients from a tertiary referral centre.

Zhou C, Urbauer DL, Fellman BM, Tamboli P, Zhang M, Matin SF, Wood CG, Karam JA.

BJU Int. 2016 May;117(5):775-82. doi: 10.1111/bju.13194. Epub 2015 Jul 5.

40.

Variability of inter-observer agreement on feasibility of partial nephrectomy before and after neoadjuvant axitinib for locally advanced renal cell carcinoma (RCC): independent analysis from a phase II trial.

Karam JA, Devine CE, Fellman BM, Urbauer DL, Abel EJ, Allaf ME, Bex A, Lane BR, Thompson RH, Wood CG.

BJU Int. 2016 Apr;117(4):629-35. doi: 10.1111/bju.13188. Epub 2015 Jun 29.

41.

Defective DNA Mismatch Repair Influences Expression of Endometrial Carcinoma Biomarkers.

Okoye EI, Bruegl AS, Fellman B, Luthra R, Broaddus RR.

Int J Gynecol Pathol. 2016 Jan;35(1):8-15. doi: 10.1097/PGP.0000000000000193.

42.

Is it all Lynch syndrome?: An assessment of family history in individuals with mismatch repair-deficient tumors.

Dempsey KM, Broaddus R, You YN, Noblin SJ, Mork M, Fellman B, Urbauer D, Daniels M, Lu K.

Genet Med. 2015 Jun;17(6):476-84. doi: 10.1038/gim.2014.131. Epub 2014 Oct 23.

43.

Attitudes toward molecular testing for personalized cancer therapy.

Yusuf RA, Rogith D, Hovick SR, Peterson SK, Burton-Chase AM, Fellman BM, Li Y, McKinney C, Bernstam EV, Meric-Bernstam F.

Cancer. 2015 Jan 15;121(2):243-50. doi: 10.1002/cncr.28966. Epub 2014 Sep 10.

44.

Overall survival after pelvic exenteration for gynecologic malignancy.

Westin SN, Rallapalli V, Fellman B, Urbauer DL, Pal N, Frumovitz MM, Ramondetta LM, Bodurka DC, Ramirez PT, Soliman PT.

Gynecol Oncol. 2014 Sep;134(3):546-51. doi: 10.1016/j.ygyno.2014.06.034. Epub 2014 Jul 9.

45.

Consequences of universal MSI/IHC in screening ENDOMETRIAL cancer patients for Lynch syndrome.

Batte BA, Bruegl AS, Daniels MS, Ring KL, Dempsey KM, Djordjevic B, Luthra R, Fellman BM, Lu KH, Broaddus RR.

Gynecol Oncol. 2014 Aug;134(2):319-25. doi: 10.1016/j.ygyno.2014.06.009. Epub 2014 Jun 14.

46.

Evaluation of clinical criteria for the identification of Lynch syndrome among unselected patients with endometrial cancer.

Bruegl AS, Djordjevic B, Batte B, Daniels M, Fellman B, Urbauer D, Luthra R, Sun C, Lu KH, Broaddus RR.

Cancer Prev Res (Phila). 2014 Jul;7(7):686-97. doi: 10.1158/1940-6207.CAPR-13-0359. Epub 2014 Apr 25.

47.

Cross-talk between EphA2 and BRaf/CRaf is a key determinant of response to Dasatinib.

Huang J, Hu W, Bottsford-Miller J, Liu T, Han HD, Zand B, Pradeep S, Roh JW, Thanapprapasr D, Dalton HJ, Pecot CV, Rupaimoole R, Lu C, Fellman B, Urbauer D, Kang Y, Jennings NB, Huang L, Deavers MT, Broaddus R, Coleman RL, Sood AK.

Clin Cancer Res. 2014 Apr 1;20(7):1846-55. doi: 10.1158/1078-0432.CCR-13-2141. Epub 2014 Jan 31.

48.

Priorities for oncology nursing research: the 2013 national survey.

LoBiondo-Wood G, Brown CG, Knobf MT, Lyon D, Mallory G, Mitchell SA, Von Ah D, Wesmiller S, Fellman B.

Oncol Nurs Forum. 2014 Jan 1;41(1):67-76. doi: 10.1188/14.ONF.67-76.

PMID:
24368240
49.

Pelvic exenteration: impact of age on surgical and oncologic outcomes.

Huang M, Iglesias DA, Westin SN, Fellman B, Urbauer D, Schmeler KM, Frumovitz M, Ramirez PT, Soliman PT.

Gynecol Oncol. 2014 Jan;132(1):114-8. doi: 10.1016/j.ygyno.2013.11.014. Epub 2013 Nov 18.

50.

Efficacy trial of an Internet-based intervention for cancer-related female sexual dysfunction.

Schover LR, Yuan Y, Fellman BM, Odensky E, Lewis PE, Martinetti P.

J Natl Compr Canc Netw. 2013 Nov;11(11):1389-97.

Supplemental Content

Loading ...
Support Center